Recuperato da: Thomsen M, Dencker D, Wrtwein G, Weikop P, Egecioglu E, Jerlhag E, et al
Its whether theyre being prescribed safely, supported appropriately, and offered by companies that put long-term patient health above short-term growth
Most people will benefit from a treatment that can fit with their lifestyle, so there's ongoing research into widening the range of treatment options." 3 | To learn how GLP-1 agonists can help with other health problems It's possible that GLP-1 therapies can also improve other health problems beyond diabetes and obesity such as kidney disease, and heart disease
(PubMed) Heise R, Skazik C, Marquardt Y, et al
The transformative potential is evident in specific contexts: for patients with high cardiovascular risk, substantial obesity, and access to comprehensive care, including nutritional support, GLP-1 agonists offer unprecedented therapeutic benefits